Elliott Katie, Haworth Emily, Bolnykh Iakov, McAllister-Williams R Hamish, Greystoke Alastair, Todd Adam, Sharp Linda
Population Health Sciences Institute, Newcastle University, Newcastle University Centre for Cancer, Newcastle upon Tyne, England, UK.
Cumbria, Northumberland, Tyne and Wear NHS Foundation Trust, Newcastle upon Tyne, UK; Newcastle Biomedical Research Centre, Newcastle University, Newcastle upon Tyne, UK; School of Pharmacy, Newcastle University, Newcastle Upon Tyne, UK.
Breast. 2025 Feb;79:103855. doi: 10.1016/j.breast.2024.103855. Epub 2024 Dec 7.
Breast cancer is the most commonly diagnosed cancer worldwide, with early detection and advanced treatments contributing to declining mortality rates. However, managing comorbid conditions, particularly mental illness, presents significant challenges for cancer treatment. This study systematically reviews and meta-analyses the impact of having a pre-existing mental illness on breast cancer treatment utilisation, focusing on specific treatments and comparing different mental illnesses. MEDLINE, EMBASE, CINAHL, and APA PsycInfo databases were searched. After screening, fifteen studies were identified as meeting the inclusion criteria. The included studies were predominantly from high-income countries, and compared breast cancer treatment in patients with and without pre-existing mental illnesses including anxiety, mood disorders, schizophrenia and psychotic disorders, and neurodevelopmental disorders. Meta-analysis revealed that patients with mental illnesses were significantly less likely to receive guideline-recommended treatments (OR = 0.78, 95 % CI 0.72-0.83, N = 5), chemotherapy (OR = 0.56, 95 % CI 0.34-0.78, N = 6), or radiotherapy (OR = 0.79, 95 % CI 0.66-0.93, N = 5). They were also significantly more likely to undergo mastectomy instead of breast-conserving surgery (OR = 1.38, 95 % CI 1.24-1.52, N = 4). Findings were consistent across different mental illnesses. This review highlights the need for targeted interventions to improve healthcare access and address provider biases, promoting better integration of mental health and oncology care.
乳腺癌是全球最常被诊断出的癌症,早期检测和先进治疗使得死亡率不断下降。然而,管理合并症,尤其是精神疾病,给癌症治疗带来了重大挑战。本研究系统回顾并荟萃分析了已有精神疾病对乳腺癌治疗利用情况的影响,重点关注特定治疗方法并比较不同精神疾病。检索了MEDLINE、EMBASE、CINAHL和APA PsycInfo数据库。筛选后,确定有15项研究符合纳入标准。纳入的研究主要来自高收入国家,比较了患有和未患有包括焦虑症、情绪障碍、精神分裂症和精神障碍以及神经发育障碍等已有精神疾病的患者的乳腺癌治疗情况。荟萃分析显示,患有精神疾病的患者接受指南推荐治疗的可能性显著降低(OR = 0.78,95% CI 0.72 - 0.83,N = 5)、接受化疗的可能性显著降低(OR = 0.56,95% CI 0.34 - 0.78,N = 6)或接受放疗的可能性显著降低(OR = 0.79,95% CI 0.66 - 0.93,N = 5)。他们接受乳房切除术而非保乳手术的可能性也显著更高(OR = 1.38,95% CI 1.24 - 1.52,N = 4)。不同精神疾病的研究结果一致。本综述强调需要有针对性的干预措施,以改善医疗服务可及性并消除医疗服务提供者的偏见,促进精神卫生与肿瘤护理的更好整合。